Meta-analysis of molecular property patterns and filtering of public datasets of antimalarial “hits” and drugs
- 1 January 2010
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 1 (5), 325-330
- https://doi.org/10.1039/c0md00129e
Abstract
Neglected infectious diseases such as tuberculosis (TB) and malaria kill millions of people annually and the oral drugs used are subject to resistance requiring the urgent development of new therapeutics. Several groups, including pharmaceutical companies, have made large sets of antimalarial screening hit compounds and the associated bioassay data available for the community to learn from and potentially optimize. We have examined both intrinsic and predicted molecular properties across these datasets and compared them with large libraries of compounds screened against Mycobacterium tuberculosis in order to identify any obvious patterns, trends or relationships. One set of antimalarial hits provided by GlaxoSmithKline appears less optimal for lead optimization compared with two other sets of screening hits we examined. Active compounds against both diseases were identified to have larger molecular weight (350–400) and logP values of 4.0, values that are, in general, distinct from the less active compounds. The antimalarial hits were also filtered with computational rules to identify potentially undesirable substructures. We were surprised that approximately 75–85% of these compounds failed one of the sets of filters that we applied during this work. The level of filter failure was much higher than for FDA approved drugs or a subset of antimalarial drugs. Both antimalarial and antituberculosis drug discovery should likely use simple available approaches to ensure that the hits derived from large scale screening are worth optimizing and do not clearly represent reactive compounds with a higher probability of toxicity in vivo.Keywords
This publication has 41 references indexed in Scilit:
- Chemical genetics of Plasmodium falciparumNature, 2010
- Thousands of chemical starting points for antimalarial lead identificationNature, 2010
- GSK/Sirtris compounds dogged by assay artifactsNature Biotechnology, 2010
- A collaborative database and computational models for tuberculosis drug discoveryMolecular BioSystems, 2010
- Antituberculosis activity of the molecular libraries screening center network libraryTuberculosis, 2009
- High-throughput screening for inhibitors of Mycobacterium tuberculosis H37RvTuberculosis, 2009
- A crowdsourcing evaluation of the NIH chemical probesNature Chemical Biology, 2009
- Novel Chemical Space Exploration via Natural ProductsJournal of Medicinal Chemistry, 2009
- Stoichiometry and Physical Chemistry of Promiscuous Aggregate-Based InhibitorsJournal of the American Chemical Society, 2008
- An Empirical Process for the Design of High-Throughput Screening Deck FiltersJournal of Chemical Information and Modeling, 2006